OncoCyte
OCX
HK$26.30
Share price
14.92%
Change (1 day)
36.52%
Change (1 year)
Categories
Revenue for OncoCyte (OCX)
Revenue in 2024 (TTM): HK$14.62 Million
According to OncoCyte
's latest financial reports the company's current revenue (TTM 
) is HK$14.59 Million. an increase over the revenue in the year 2023 that were of HK$11.73 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for OncoCyte from 2015 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | HK$14.6 M | 24.4% |
| 2023 | HK$11.73 M | -152.42% |
| 2022 | -HK$22.4 Million | -137.17% |
| 2021 | HK$60.25 M | 538.64% |
| 2020 | HK$9.43 M | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |